Stone House Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$93.5K Buy
258
+1
+0.4% +$342 0.01% 161
2026
Q1
$90.5K Buy
257
+13
+5% +$4.63K 0.02% 131
2025
Q4
$80K Buy
244
+11
+5% +$3.49K 0.01% 129
2025
Q3
$65.8K Buy
233
+1
+0.4% +$290 0.01% 134
2025
Q2
$64.7K Buy
232
+15
+7% +$4.25K 0.01% 135
2025
Q1
$67.7K Buy
+217
New +$64.1K 0.01% 125
2024
Q4
– Sell
-216
Closed -$69.5K – 67
2024
Q3
$69.5K Buy
216
+1
+0.5% +$327 0.01% 97
2024
Q2
$67.1K Buy
215
+1
+0.5% +$294 0.02% 102
2024
Q1
$60.8K Buy
214
+5
+2% +$1.46K 0.01% 111
2023
Q4
$60.2K Buy
209
+177
+553% +$48.2K 0.02% 80
2023
Q3
$8.67K Hold
32
– – ﹤0.01% 172
2023
Q2
$7.1K Hold
32
– – ﹤0.01% 184
2023
Q1
$7.66K Buy
+32
New +$7.86K ﹤0.01% 181
2019
Q2
– Sell
-28
Closed -$5K – 41
2019
Q1
$5K Buy
+28
New +$5.35K ﹤0.01% 174

Other funds holding AMGN

Stone House Investment Management's AMGN Position: Q2 2026 in Review

Stone House Investment Management increased its Amgen (AMGN) stake by 0.39% in Q2 2026, buying an estimated $342 and bringing the position to 258 shares worth $93.5K. The position accounts for 0.01% of the portfolio, ranked #161.

Stone House Investment Management first reported a position in AMGN in Q1 2019 and has held it in 14 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Stone House Investment Management held 258 shares of Amgen worth $93.5K as of Q2 2026.
  • Stone House Investment Management bought 1 Amgen share in Q2 2026, an estimated $342.
  • Amgen made up 0.01% of Stone House Investment Management's portfolio in Q2 2026, its #161 holding.
  • Stone House Investment Management first reported a position in Amgen in Q1 2019 and has held it in 14 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.